Quick Takeaways
- Alta Partners LLC filed SCHEDULE 13G/A for AEON Biopharma, Inc. Common Stock (AEON).
- Disclosed ownership: 5.1%.
- Date of event: 30 Jun 2025.
Alta Partners LLC - 30 Jun 2025 SCHEDULE 13G/A Report for AEON Biopharma, Inc. Common Stock (AEON)
- Filing Manager
- Alta Partners LLC
- Reporting Manager
- Alta Partners LLC
- Security
- AEON Biopharma, Inc. Common Stock
- Symbol
- AEON
- Shares outstanding
- 11,496,765 shares
- Disclosed Ownership
- 586,335 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 09 Jul 2025, 12:33:59 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 10 Mar 2025
- Next filing
- 14 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Alta Partners LLC disclosed 5.1% ownership in AEON Biopharma, Inc. Common Stock (AEON) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 10 Mar 2025.
- Current filing was accepted on 09 Jul 2025, 12:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alta Partners LLC | 5.1% | 586,335 | 586,335 | 0 | /s/ Steven Cohen | Steven Cohen, Managing Member |